Biotage Stock

Biotage P/E 2024

Biotage P/E

53.11

Ticker

BIOT.ST

ISIN

SE0000454746

WKN

A0MNB5

As of Sep 17, 2024, Biotage's P/E ratio was 53.11, a 21.62% change from the 43.67 P/E ratio recorded in the previous year.

The Biotage P/E history

Biotage Aktienanalyse

What does Biotage do?

Biotage AB is a Swedish company founded in 1983. Since then, the company has become an international leader in the development, manufacturing, and marketing of equipment, chemicals, and accessories for organic and medicinal chemistry, pharmacy, biochemistry, and food analysis. The company's business model is based on the development and marketing of innovative instruments and technologies for analytics and chromatography. Consumables and accessory products are also an important part of the business model. Biotage offers customized solutions tailored to each customer's specific needs. Biotage systems are widely used in the pharmaceutical, biotech, and academic sectors. The company is divided into four main divisions: chromatography, spectroscopy, analytics, and synthesis. In the chromatography division, Biotage offers a wide range of systems for sample preparation and analysis, including flash chromatography systems, HPLC systems, and automation solutions for column development. In the spectroscopy division, Biotage offers systems for molecular structure determination, including NMR spectrometers and FT-IR spectrometers. In the analytics division, the company specializes in mass spectrometry and offers a wide range of instruments and accessories, including HPLC-MS systems, MALDI-TOF systems, and LC-MS applications. In the synthesis division, the focus is on the development and marketing of tools for the synthesis, purification, and analysis of peptides and synthesis kits. Biotage is also known for its wide range of chemicals and accessory products. The company offers a variety of solvents, catalysts, reagents, and separation columns that can be used in organic, pharmaceutical, and biological synthesis. Accessory products include items such as activated carbon filter cartridges or membranes for various chromatography systems. Despite the wide range of products, Biotage has focused on specialized markets, particularly drug research and development, peptide synthesis, and the production of specialty chemicals. In these markets, the devices and chemicals are used to develop and produce medications and important blockbuster compounds. In conclusion, Biotage is a company that focuses on the development and marketing of instruments and technologies for analytics and chromatography. Thanks to its strong market presence and innovative products, the company has become an internationally recognized manufacturer. Biotage is headquartered in Sweden, but its global network of sales and service centers enables global presence and development. Biotage ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Biotage's P/E Ratio

The Price to Earnings (P/E) Ratio of Biotage is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Biotage's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Biotage is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Biotage’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Biotage stock

What is the price-to-earnings ratio of Biotage?

The price-earnings ratio of Biotage is currently 53.11.

How has the price-earnings ratio of Biotage changed compared to last year?

The price-to-earnings ratio of Biotage has increased by 21.62% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Biotage high compared to other companies?

Yes, the price-to-earnings ratio of Biotage is high compared to other companies.

How does an increase in the price-earnings ratio of Biotage affect the company?

An increase in the price-earnings ratio of Biotage would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Biotage affect the company?

A decrease in the price-earnings ratio of Biotage would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Biotage?

Some factors that influence the price-earnings ratio of Biotage are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Biotage pay?

Over the past 12 months, Biotage paid a dividend of 1.6 SEK . This corresponds to a dividend yield of about 0.87 %. For the coming 12 months, Biotage is expected to pay a dividend of 1.75 SEK.

What is the dividend yield of Biotage?

The current dividend yield of Biotage is 0.87 %.

When does Biotage pay dividends?

Biotage pays a quarterly dividend. This is distributed in the months of May, May, May, May.

How secure is the dividend of Biotage?

Biotage paid dividends every year for the past 8 years.

What is the dividend of Biotage?

For the upcoming 12 months, dividends amounting to 1.75 SEK are expected. This corresponds to a dividend yield of 0.95 %.

In which sector is Biotage located?

Biotage is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biotage kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biotage from 5/3/2024 amounting to 1.6 SEK, you needed to have the stock in your portfolio before the ex-date on 4/26/2024.

When did Biotage pay the last dividend?

The last dividend was paid out on 5/3/2024.

What was the dividend of Biotage in the year 2023?

In the year 2023, Biotage distributed 1.55 SEK as dividends.

In which currency does Biotage pay out the dividend?

The dividends of Biotage are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biotage

Our stock analysis for Biotage Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biotage Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.